CBIO Stock Analysis: Buy, Sell, or Hold?
CBIO - Crescent Biopharma, Inc. Common Stock
$9.59
-0.55 (-5.47%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 12, 2026
12d
Get Alerted When CBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CBIO is currently trading at $9.59, which is considered oversold relative to its 30-day fair value range of $10.72 to $12.91.
Technical Outlook: Technically, CBIO is showing sideways momentum. The price is currently testing key support at $9.43. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: CBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $22.00 (+116.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CBIO is showing sideways momentum. The price is currently testing key support at $9.43. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: CBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $22.00 (+116.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$10.72 -
$12.91
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding CBIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.5%)
- BULLISH: Trading 116.9% below Wall St target ($22.00)
- CAUTION: 5-day price weakness (-25.1%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$10.72 -
$12.91
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$9.43
Resistance Level
$14.71
Current Trend
Sideways
Fundamental Context
Wall Street Target
$22.00
(+116.9%)
Last updated: January 30, 2026 5:42 PM ET
Data refreshes hourly during market hours. Next update: 6:42 PM
Data refreshes hourly during market hours. Next update: 6:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBIO showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$13 | 63 BUY |
Advanced CBIO Option Strategies
Professional options setups generated by AI based on today's CBIO price and gamma walls.